Log In
Print
BCIQ
Print
Print this Print this
 

Recombinant human nerve growth factor (rhNGF)

  Manage Alerts
Collapse Summary General Information
Company Dompe Farmaceutici S.p.A.
DescriptionRecombinant human nerve growth factor (rhNGF)
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase I/II
Standard Indication Ophthalmic (unspecified)
Indication DetailsTreat neurotrophic keratitis; Treat retinitis pigmentosa (RP); Treat stage 2 and 3 neurotrophic keratitis
Regulatory Designation

U.S. - Orphan Drug (Treat retinitis pigmentosa (RP));
EU - Orphan Drug (Treat retinitis pigmentosa (RP))

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today